Scientists are launching human trials of a “life-changing” drug that may alleviate involuntary and erratic “jerking” brought on by Parkinson’s treatment. Here’s the most recent on the groundbreaking analysis.
The drug, NLX-112, has the potential to scale back dyskinesia and “improve movement symptoms of Parkinson’s”, stated Parkinson’s UK.
The analysis charity defined: “Dyskinesias are involuntary, erratic, writhing actions of the face, arms, legs or trunk.
“They may additionally trigger fast jerking or gradual and prolonged muscle spasms.”